324 related articles for article (PubMed ID: 20136782)
1. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an HPA-1- to -16-typed platelet donor registry in China.
Feng ML; Liu DZ; Shen W; Wang JL; Guo ZH; Zhang X; Du KM; Qian KC; Zhao TM
Transfus Med; 2006 Oct; 16(5):369-74. PubMed ID: 16999761
[TBL] [Abstract][Full Text] [Related]
3. Human platelet-specific antigen frequencies in Indonesian population.
Asmarinah ; Dharma R; Ritchie NK; Rahayu S; Putricahya E; Santoso S
Transfus Med; 2013 Aug; 23(4):250-3. PubMed ID: 23617356
[TBL] [Abstract][Full Text] [Related]
4. Human platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan.
Bhatti FA; Uddin M; Ahmed A; Bugert P
Transfus Med; 2010 Apr; 20(2):78-87. PubMed ID: 19948007
[TBL] [Abstract][Full Text] [Related]
5. Human platelet antigen frequencies of platelet donors in the French population determined by polymerase chain reaction with sequence-specific primers.
Mérieux Y; Debost M; Bernaud J; Raffin A; Meyer F; Rigal D
Pathol Biol (Paris); 1997 Nov; 45(9):697-700. PubMed ID: 9538466
[TBL] [Abstract][Full Text] [Related]
6. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
7. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
8. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors.
Shehata N; Denomme GA; Hannach B; Banning N; Freedman J
Transfusion; 2011 Sep; 51(9):2028-33. PubMed ID: 21392014
[TBL] [Abstract][Full Text] [Related]
9. The allele frequencies of HPA 1-16 determined by PCR-SSP in Chinese Cantonese donors.
Nie YM; Zhou HJ; Fu YS; Wang CX; Ma JP
Transfus Med; 2010 Dec; 20(6):376-82. PubMed ID: 20667040
[TBL] [Abstract][Full Text] [Related]
10. [Practical usefulness of a donor registry with determined HLA class I antigens--current personal experience].
Gronkowska A; Uhrynowska M; Gromadzka G; Zupańska B
Acta Haematol Pol; 1993; 24(2):161-7. PubMed ID: 8372616
[TBL] [Abstract][Full Text] [Related]
11. A mini-review on platelet refractoriness.
Rebulla P
Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
[TBL] [Abstract][Full Text] [Related]
12. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
13. Febrile nonhaemolytic transfusion reaction caused by antibodies against human platelet antigen 5a.
Tazzari PL; Bontadini A; Zamagni C; Ricci F; Fruet F; Iannelli S; Conte R
Transfus Med; 2005 Oct; 15(5):443-4. PubMed ID: 16202061
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of human platelet antigens in ethnic Northeastern Thais by the polymerase chain reaction-sequence specific primer technique.
Romphruk AV; Akahat J; Srivanichrak P; Puapairoj C; Romphruk A; Leelayuwat C
J Med Assoc Thai; 2000 Nov; 83(11):1333-9. PubMed ID: 11215863
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of genetic polymorphism in randomized donor's HPA 1-16 antigens and establishment of typed platelet donor data bank].
Sun GD; Duan XM; Zhang YP; Yin ZZ; Niu XL; Li YF; Niu HJ; Zhao YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):889-95. PubMed ID: 16277865
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of transfusion effect of different platelet matching schemes in patients with platelet transfusion refractoriness].
Liang YJ; Wang H; Zhao PZ; Wang F; Li Q; Xu Y; Wu YX; Zhang DM; He XH
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):865-869. PubMed ID: 38462363
[No Abstract] [Full Text] [Related]
17. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
18. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders.
Curtis BR
Semin Thromb Hemost; 2008 Sep; 34(6):539-48. PubMed ID: 19085653
[TBL] [Abstract][Full Text] [Related]
19. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
20. [Study of the platelet GP specific antibodies and HLA antibodies expression in platelet transfusion refractoriness patients].
Xia WJ; Ye X; Deng J; Chen YK; Xu XZ; Ding HQ; Luo GP; Fu YS
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):594-8. PubMed ID: 21122318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
